JNK Polyklonaler Antikörper

JNK Polyklonal Antikörper für IF, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Affe, human, Maus, Ratte und mehr (1)

Anwendung

WB, IP, IHC, IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 51153-1-AP

Synonyme

c Jun N terminal kinase 2, JNK 55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, MAP kinase 9, MAPK 9, MAPK9, p54a, p54aSAPK, PRKM9, SAPK



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHeLa-Zellen, A549-Zellen, COS-7-Zellen, NIH/3T3-Zellen
Erfolgreiche IPHeLa-Zellen
Erfolgreiche Detektion in IFHeLa-Zellen, HUVEC-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:2000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunfluoreszenz (IF)IF : 1:10-1:100
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

WBSee 5 publications below
IHCSee 1 publications below

Produktinformation

51153-1-AP bindet in WB, IP, IHC, IF, ELISA JNK und zeigt Reaktivität mit Affe, human, Maus, Ratten

Getestete Reaktivität Affe, human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Kaninchen, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen JNK fusion protein Ag1442
Vollständiger Name mitogen-activated protein kinase 9
Berechnetes Molekulargewicht 424 aa, 48 kDa
Beobachtetes Molekulargewicht 44-55 kDa
GenBank-ZugangsnummerBC032539
Gene symbol MAPK9
Gene ID (NCBI) 5601
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

c-Jun N-terminal kinases (JNKs), first characterized as stress-activated members of the mitogen-activated protein kinase (MAPK) family, have shown their critical roles in the development of a number of cellular progress and diseases, including proliferation, embryonic development, apoptosis, diabetes, neurodegeneration and liver disease (PMID: 19900593). JNK1, JNK2, JNK3 also name as MAPK8, MAPK9, MAPK10, JNK1 and JNK2 are ubiquitously expressed, but JNK3 is expressed primarily in the brain (PMID: 27698029). This antibody can recognize JNK1, JNK2 and JNK3, we get bands around 44-55 kDa.

Protokolle

Produktspezifische Protokolle
WB protocol for JNK antibody 51153-1-APProtokoll herunterladen
IF protocol for JNK antibody 51153-1-APProtokoll herunterladen
IP protocol for JNK antibody 51153-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Adv Mater

m6 A Reader YTHDF1-Targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy via Epigenetic and Immune Regulation

Authors - Qing You
humanWB

Nat Commun

SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation.

Authors - Peiyuan Zhang
humanWB

Biomed Pharmacother

Icariside II suppresses cervical cancer cell migration through JNK modulated matrix metalloproteinase-2/9 inhibition in vitro and in vivo.

Authors - Ya-Sai Sun
ratWB

Neurochem Res

Exogenous TIPE2 Inhibit TAK1 to Improve Inflammation and Neuropathic Pain Induced by Sciatic Nerve Injury Through Inactivating NF-κB and JNK.

Authors - Xuehua Sun
rabbitWB

Microb Pathog

Polysaccharides from Citrus grandis L. Osbeck suppress inflammation and relieve chronic pharyngitis.

Authors - Liyan Chen
mouseIHC

J Ethnopharmacol

Integrated miRNA and mRNA omics reveal dioscin suppresses migration and invasion via MEK/ERK and JNK signaling pathways in human endometrial carcinoma in vivo and in vitro

Authors - Xiao-Li Li